Loading clinical trials...
Loading clinical trials...
A Phase 1, Open Label, Non-randomized, Multi-Center Trial of AB-205 in Adults With Lymphoma Undergoing High-Dose Therapy and Autologous Stem Cell Transplantation
Conditions
Interventions
AB-205
Locations
9
United States
City of Hope Comprehensive Cancer Center
Duarte, California, United States
UC Davis Comprehensive Cancer Center
Sacramento, California, United States
UC San Diego Moores Cancer Center
San Diego, California, United States
The University of California San Francisco
San Francisco, California, United States
University of Michigan
Ann Arbor, Michigan, United States
Hackensack University Medical Center
Hackensack, New Jersey, United States
Start Date
May 7, 2019
Primary Completion Date
November 18, 2020
Completion Date
November 8, 2021
Last Updated
March 3, 2022
NCT07249528
NCT03050268
NCT06870760
NCT03618550
NCT06090539
NCT05998642
Lead Sponsor
Angiocrine Bioscience
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions